江蘇康潤生物科技有限公司是中國江蘇省內一家集研發、生產、銷售于一體的大型現代化生物制藥企業，國家高新技術企業。公司成立于2011年，注冊資金1.89億元人民幣，坐落于中國江蘇常州市國家高新區。
公司占地52000平米，其中廠房建筑41000平米，目前已建有狂犬疫苗車間，流感疫苗車間，分包裝車間及研發中試車間，同時配套生物安全實驗室、分析檢測中心、動物實驗中心和大規模動物細胞培養工程中心。
公司現有員工251人，現有產品流感病毒裂解疫苗，在研產品凍干人用狂犬病疫苗（Vero細胞），四價流感病毒裂解疫苗，氣管炎疫苗等。同時擁有多項專利技術，支撐產品開發，作為專業的病毒疫苗制造商，為國內外提供優質的人用疫苗及服務。
通過多年來不斷的研發創新，康潤生物正逐步建成產線豐富、結構優良的疫苗基地，為人民群眾提供優質的產品和滿意的服務，潤澤生命、守護健康。
Company Profile
Jiangsu CuroVax Co., Ltd is a large modern bio-pharmaceutical enterprise specialized in research, development, production, sales in Jiangsu Province, China, and it is also a national high-tech enterprise. Established in 2011 with the registered capital of CNY189,000,000, the company is located in Changzhou National High-tech Zone, Jiangsu Province, China.
Covering an area of 52000m2, the company has the plant buildings of 41000m2, and the company now has built the rabies vaccine workshop, influenza vaccine workshop, sub-packing workshop and R&D pilot test workshop with the supporting bio-safety laboratory, analysis and testing center, animal experimental center and the large-scale animal cell culture engineering center.
The company now has 251 employees, and the current products include the split influenza vaccine, freeze-dried rabies vaccine for human use (Vero cell) under research, tetravalent split influenza vaccine, and tracheitis vaccine etc. Meanwhile, the company has a number of patented technologies to support the product development, providing high-quality human vaccines and services at home and abroad as a professional virus vaccine manufacturer.
With years of continuous research and innovation, CuroVax is gradually establishing the vaccine base with abundant production lines and excellent structure, providing high quality products and satisfying services for the public, moistening lives and protecting the public health.